Health

Health•Oct 6, 2026

The 2026 Medicine Nobel Honors a Light Switch for Brain Cells

Karl Deisseroth, Peter Hegemann and Georg Nagel won the 2026 medicine Nobel for discoveries that created optogenetics, a method for controlling selected neurons with light. The technique transformed causal brain research, but most therapeutic uses still require experimental gene delivery and light hardware.

Health•Oct 3, 2026

AI Read Short Stress Stories to Separate Two Healthcare-Worker Profiles

A six-week study used recorded stress narratives from healthcare workers to distinguish two self-report-derived stress profiles with an AUROC of 0.75. The result is a proof of concept, not a clinical diagnosis, and has not been validated outside the study cohort.

Health•Sep 30, 2026

Three-Cell Niche Preceded Wasting in Pancreatic Cancer Models

A Cell study identified adjacent SEMA4A-positive tumour cells, AQP9-positive macrophages and LOXL2-positive fibroblasts that formed a cachexia-promoting niche before measurable tissue loss in pancreatic-cancer models. The finding suggests future markers and targets, but it has not produced a patient test or treatment.

Health•Sep 25, 2026

Tiny Implants Used Body Tissue to Coordinate a Rat’s Limbs

Georgia Tech researchers built a low-power network that sends simple electrical commands through body tissue between wearable and implantable devices. Sub-3-millimetre implants coordinated limb movement in a rat, but the system remains a preclinical prototype with no human safety or therapeutic evidence.

Health•Sep 25, 2026

FDA Approves a Weekly Insulin for Adults With Type 2 Diabetes

The FDA approved Lilly’s Onswik as a once-weekly basal insulin for adults with type 2 diabetes. Four Phase 3 trials found blood-sugar control that was not inferior to daily basal insulin, but the drug is not approved for type 1 diabetes and still carries hypoglycaemia risks.

Health•Sep 18, 2026

Azetukalner Depression Trials Paused After Rare Neuropsychiatric Events

Xenon paused new enrollment in Phase III azetukalner studies for major and bipolar depression after neuropsychiatric adverse events emerged. Current participants continue, but detailed event rates and a causal analysis remain unpublished.

Health•Sep 15, 2026

One Brain Implant Decoded Speech and Gestures at the Same Time

A 253-electrode brain implant decoded attempted speech and upper-body gestures simultaneously in people with severe paralysis, using both outputs to control a digital avatar. The proof of concept adds expressiveness beyond text alone, but involved three participants, restricted vocabularies and a wired research system.

Health•Sep 13, 2026

mRNA Nanoparticles Reprogrammed Tumour-Supporting Immune Cells in Mice

Targeted lipid nanoparticles delivered mRNA and an immune stimulant into tumour-associated macrophages in mice. Suppressive macrophages fell by more than 60% and CXCL9 rose fourfold, but the work remains preclinical and adding checkpoint drugs did not further slow tumour growth.

Health•Sep 10, 2026

A Monthly Antibody Cut COPD Flare-Ups by About 30%

Two replicate Phase III trials found that tozorakimab reduced annual moderate or severe COPD exacerbations by roughly 30% across a broad patient population. The antibody remains investigational, shows no established mortality benefit and is under priority review by the US Food and Drug Administration.

Health•Sep 9, 2026

Gut Bacteria Tracked Inflammation Better Than Age in 1,199 Adults

In 1,199 Danish adults, gut-microbiota composition explained more variation than age across most inflammatory and physiological measures. One low-diversity pattern resembled an inflammation profile seen up to 37 years later and predicted more diagnoses, but the observational study cannot establish cause or support a consumer aging test.

Health•Sep 8, 2026

Six Aging Clocks Agreed on One Drug, but They Cannot Prove It Slowed Aging

Six protein-based aging clocks judged blood samples from 42 lung-disease patients as biologically younger after rentosertib treatment. The agreement is intriguing, but this secondary analysis cannot show that the AI-designed drug slowed aging rather than changing proteins affected by pulmonary fibrosis.

Health•Sep 4, 2026

A Pig Kidney Kept a Man Off Dialysis for 271 Days

A genetically edited pig kidney kept one patient off dialysis for 271 days before failing. He later received a human kidney that worked well during six months of follow-up, making the case the first reported pig-to-human kidney bridge, but still only a single-patient result.

Health•Aug 29, 2026

BioNTech Stopped an mRNA Cancer Vaccine Trial After a Survival Imbalance

BioNTech and Genentech ended a Phase 2 colorectal-cancer trial after an independent board found an overall-survival imbalance and judged further study unlikely to show benefit. The size and direction of that imbalance remain undisclosed, and the board reported no new safety signal tied to the vaccine.

Health•Aug 28, 2026

Engineered tRNA Restored a Missing Protein in Cystic Fibrosis Models

Researchers engineered transfer RNA and a lipid carrier to restore functional CFTR protein in cells, mice and patient-derived cystic fibrosis organoids carrying premature stop mutations. The platform could eventually address similar errors across many genes, but it remains preclinical and has not been tested as a treatment in people.

Health•Aug 27, 2026

A Pancreatic Cancer Drug That Doubled Median Survival Is Now Approved

The FDA approved daraxonrasib for defined groups of adults with metastatic pancreatic adenocarcinoma after a 500-person trial doubled median survival versus chemotherapy. The once-daily RAS inhibitor is not a cure, carries serious risks and has a list price near $39,800 per month.

Health•Aug 21, 2026

A Blood Test May Predict a Weak Vaccine Response Before the Shot

Researchers analyzed 8,687 blood samples from 4,089 people and found that pre-vaccination antibody patterns could help identify weak COVID-19 vaccine responders. The approach may eventually support more personalized protection, but it remains a retrospective research model and has not been validated as a clinical test or across other vaccines.

Health•Aug 20, 2026

A Heartbeat-Powered Pacemaker Worked in a Pig for One Month

Researchers fitted a leadless pacemaker with a tiny generator that converts heart motion into electricity, then demonstrated cardiac stimulation during a one-month pig study. The prototype addresses a real battery-replacement problem, but weaker output inside the heart and the absence of human testing keep it years from clinical use.

Health•Aug 18, 2026

More Childhood Screen Time Was Linked to Sharper Teen Thinking

An eight-year Finnish study following 260 children found that higher cumulative screen time since childhood was linked to better cognitive test scores, not worse, in adolescence. Researchers stress this is a correlational study, not proof of causation, and that what kind of screen activity happens may matter more than how long it lasts.

Health•Aug 18, 2026

This Breast Cancer Hijacks Immune Cells to Grow Its Own Nerve Supply

University of Oklahoma researchers found that triple-negative breast cancer, one of the hardest types to treat, recruits immune cells that release a protein drawing nerves into the tumor to fuel its growth and treatment resistance. Blocking that signal with a commercially available drug significantly slowed tumor growth in mice, and real patient data showed a matching pattern.

Health•Aug 15, 2026

High Blood Sugar Helps Cancer Cells Hide From Immune Cells

A new lab study finds that high blood sugar thickens the protective sugar coating cancer cells use to hide from the immune system, but only when cells are grown in lab conditions mimicking a tumor's stiff microenvironment. Blocking a protein called HSF1 stopped the effect in these lab tests, pointing to a possible future drug target.

Health•Aug 14, 2026

A Three-Drug Combination Cleared HIV in Baby Monkeys for a Year

A one-time combination of antiretroviral drugs, antibodies, and an experimental CCR5-blocking therapy left eight infant macaques with no detectable HIV a year after treatment stopped, when given within three days of infection. Researchers call the result unexpected and want to test it in people next, starting with newly exposed adults.

Health•Aug 14, 2026

Three Minutes of All-Out Cycling Changed 714 Blood Proteins

In 10 healthy young men, six 30-second cycle sprints rapidly changed 714 measured blood proteins, far more than 90 minutes of moderate cycling in a separate nine-person group. The molecular surge is striking, but it does not prove that sprint intervals replace longer exercise or prevent disease.

Health•Aug 7, 2026

A Cholesterol-Filtering Treatment Also Pulled "Forever Chemicals" Out of Patients' Blood

German doctors treating patients with a decades-old blood-filtering therapy for severe cholesterol noticed something unexpected: PFAS "forever chemicals" dropped too, and detectable plastic particles turned up in patients' blood for the first time. The finding is an early, small, uncontrolled observation, not proof the treatment clears pollution from the body.

Health•Aug 4, 2026

Scientists Mapped 60 Human Vagus Nerves to Help Make Stimulation More Precise

Researchers released an open anatomical atlas built from 60 vagus nerves donated by 30 people. It could guide more selective stimulation devices by revealing internal nerve bundles, but the work used cadaveric tissue and has not yet improved treatment in a clinical trial.